A 52-year-old man was evaluated for incidentally discovered bilateral adrenal masses. He had drugresistant hypertension but lacked Cushingoid features. Endocrinological tests revealed autonomous secretion of cortisol and aldosterone with suppressed plasma ACTH and renin activity. A selective adrenal venous sampling demonstrated aldosterone hypersecretion from the left adrenal vein. The clinical diagnosis of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia (AIMAH) associated with primary aldosteronism was made, and he underwent left adrenalectomy; the resected adrenal lesion was consistent with the pathological diagnosis of AIMAH coexistent with aldosterone-producing adenoma (APA). This is a very rare case of AIMAH with concomitant unilateral APA, whose hypertension improved after surgery.
Introduction
Adrenocorticotrophic hormone (ACTH)-independent macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing's syndrome (CS), accounting for less than 1% of adrenal CS (1) . However, it has been recently recognized that AIMAH is found incidentally by abdominal imaging tests, such as ultrasonography, CT and MRI scans.
On the other hand, primary aldosteronism (PA) characterized by autonomous aldosterone hypersecretion constitutes mainly two subtypes, aldosterone-producing adenoma (APA) and bilateral idiopathic hyperaldosteronism (IHA). PA is currently considered to be a more common disease causing secondary hypertension than previously believed; its prevalence among hypertensive patients has been reported to be 5-15% (2) . However, to date only a few cases of PA with CS due to a solitary adenoma co-secreting aldosterone and cortisol have been reported (3) . To the best of our knowledge, only a few cases of AIMAH associated with PA have been reported (4, (6) (7) (8) .
We herein describe a very rare case of AIMAH associated with PA due to unilateral APA, as localized by selective adrenal venous sampling (AVS) and confirmed by the histopathological and immunohistochemical analysis of the resected adrenal specimen. He was 175 cm tall and weighed 119.4 kg (body mass index: 39 kg/m 2 ). His blood pressure was 174/86 mmHg with anti-hypertensive drugs, including amlodipine (5 mg), valsartan (80 mg), doxazosin (1 mg) and spironolactone (50 mg). He had no Cushingoid features, such as central obesity, moon face, skin atrophy, purple striae or buffalo hump. Laboratory examination showed a low normal serum potassium level, elevated fasting immunoreactive insulin levels and LDL-cholesterol levels, but normal fasting glucose and glycosylated hemoglobin levels ( Table 1 ). Endocrine tests ( Table 2 ) revealed normal basal cortisol levels, suppressed plasma ACTH level, aldosterone/renin ratio (ARR) of 200 and normal 24 hour-urinary excretion of free cortisol, but an increased urinary excretion of 17-OHCS and aldosterone. Dynamic endocrine tests showed altered circadian rhythm of cortisol with complete suppression of plasma ACTH, nonsuppressibility of cortisol by high-dose (8 mg) dexamethasone suppression test (DST), hyporesponse of ACTH and cortisol to CRH stimulation, and hyperresponse of cortisol and aldosterone to ACTH stimulation ( Table 2 ). These data are consistent with the diagnosis of subclinical CS (SCS) as proposed from the Committee on "the Disorders of Adrenal Hormones" by the Ministry of Health and Welfare of Japan, 1996 (10) . Stimulation with furosemide plus upright posture showed suppressed response of plasma renin activity (PRA), consistent with the diagnosis of PA ( Table 2) .
Computed tomography (CT) scan of the abdomen revealed the presence of bilateral adrenal masses, whose sizes were 4×3×2.5 cm in the left adrenal and 1×2.5×2 cm in the right adrenal, respectively ( Fig. 1a ). 131 I-Adosterol scintigraphy showed an increased uptake of radioactivity by bilateral adrenals, being more predominant in the left side ( Fig. 1b) . Collectively, these clinical endocrine and imaging findings were consistent with the diagnosis of AIMAH accompanied with PA. A selective AVS was performed to localize the preferential secretion of aldosterone (Fig. 2) . The aldosterone level in the left adrenal vein was greater than 14,000 pg/mL after ACTH stimulation (5), the lateralized ratio (LR) of the left to the right side was 4.3, and the contralateral ratio (CR) was 0.7. The results of AVS confirmed aldosterone hypersecretion from the left adrenal vein with comparable cortisol secretion from bilateral adrenal glands.
After obtaining informed consent, the patient underwent left adrenalectomy. The resected left adrenal mass was 4.0× 2.5×2.6 cm in size, consisting of multiple yellow nodules, ranging from a few mm to 40 mm in diameter ( Fig. 3 ). His- tologically, these nodules were composed of large clear cells with positive immunostaining for 3β-hydroxysteroid dehydrogenase (3β-HSD) and small compact cells with positive immunostaining for P450c17, consistent with the pathological diagnosis of AIMAH. In the non-nodular region, a wellencapsulated microadenoma ( 5 mm) composed of large clear cells with positive immunoreactivity for 3β-HSD, but negative for P450c17, was present, while zona glomerulosa cells showed negative immunoreactivity for 3β-HSD, all compatible with the pathological diagnosis of APA. The postoperative course was uneventful without glucocorticoid replacement. Shortly after operation, his serum potassium level became normalized and blood pressure (120/70 mmHg) was well controlled only with amlodipine (5 mg).
Postoperative endocrine data revealed normal PAC with PRA normally responded to furosemide upright posture stimulation ( Table 2) , whereas suppressed plasma ACTH and normal cortisol levels with its nonsuppressibility to low-dose (1 mg) dexamethasone remained unchanged ( Table 2 ).
Discussion
It has been reported that concomitant secretion of various biologically inactive steroid metabolites other than cortisol frequently occurs in AIMAH (1) . However, to date there have been only a few cases with AIMAH accompanying PA reported (4, (6) (7) (8) . In the present case, bilateral adrenal nodular enlargement by CT scan, lack of Cushingoid features, normal basal plasma and urinary cortisol levels, nonsuppressibility of cortisol to high-dose (8 mg) DST, suppressed ACTH secretion, and hyporesponse to CRH stimulation, caused by AIMAH as confirmed by the histopathological findings of the resected adrenal specimen, are all consistent with the diagnosis of SCS. In addition to poor PRA response after stimulation with furosemide-upright posture as a confirmatory test for PA, a unilateral source of aldosterone hypersecretion was confirmed by employing selective AVS with ACTH stimulation. Furthermore, a solitary microadenoma found in the resected left adrenal specimen was immunohistochemically compatible with APA. In fact, the suppressed PRA and increased PAC became normalized after left adrenalectomy. This is the very rare case of AIMAH accompanied with APA as confirmed by the histopathological and immunohistochemical analysis. AVS is currently recognized as the gold standard to determine the lateralization of aldosterone hypersecretion in PA. Recently, clinical practice guidelines for case detection, diagnosis and treatment of PA have been recommended, and several diagnostic criteria by AVS have been proposed (5, 9) . Unilateral aldosterone hypersecretion is considered on the basis of the following criteria: 1) LR defined as the gradient of aldosterone-cortisol ratio (A/C) in the dominant adrenal vein over that in the non-dominant adrenal vein after ACTH stimulation is greater than 4 (9), 2) LR in the absence of ACTH stimulation is greater than 2 (9), 3) A/C from adrenal vein is at least 2.5 times greater than that from the peripheral vein and the A/C in the contralateral adrenal vein (CR) is no higher than peripheral vein (CR<1) (9), and 4) absolute value of PAC in adrenal venous effluent is greater than 14,000 pg/mL (5) . In the present case, 3 [1, 3 and 4] out of 4 criteria were fulfilled for lateralization of aldosterone hypersecretion from the left adrenal gland. Since LR by A/C could be affected if the asymmetric cortisol hypersecretion takes place, LR by PAC and/or absolute PAC appears more reliable to determine the source of aldosterone hypersecretion under the excessive cortisol secretion by concomitant cortisol-secreting adenoma and/or AIMAH, such as in the present case.
Postoperatively, drug-resistant hypertension and hypokalemia in the present case were resolved along with the normalization of PRA and PAC after left adrenalectomy. Therefore, it is strongly suggested that APA plays an important role in the development of hypertension and hypokalemia. However, given the elevated urinary excretion of 17-OHCS with a normal urinary excretion of free cortisol, it is possible to speculate that intermediate steroids with weak mineralocorticoid activities, such as deoxycorticosterone and corticosterone, excessively secreted from AIMAH may have been partly involved in the development of hypertension in our 
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case, although we did not study steroid mapping. Although the clinical significance of surgical treatment in patients with AIMAH by either unilateral or bilateral adrenalectomy remains controversial, unilateral adrenalectomy for the removal of APA and hemi-side AIMAH was considered reasonable in our case. It has been shown that aberrant and/or exaggerated expression of multiple G protein-coupled receptors, including receptor for gastric inhibitory peptide (GIP), β-adrenergic agonist, vasopressin, serotonin, and luteinizing hormone/human chronic gonadotropin (LH/hCG), are involved in the pathogenesis of AIMAH with abnormal proliferation of zona fasciculata cells and with dysregulation of steroidgenesis (1). Recently, it has been shown that the receptors for GIP, LH, thyrotropin-releasing hormone and gonadotropin-releasing hormone aberrantly expressed are functionally related to the abnormal aldosterone secretion in certain APAs (11, 12) . It is therefore intriguing to speculate that the expression of common aberrant receptor(s) yet-unspecified might be involved in the concurrent development of AIMAH and APA in our case, although further study is needed to prove such assumption.
In summary, this is a rare case of AIMAH associated with PA due to unilateral APA, which was localized by a selec-tive AVS and confirmed by the histopathological and immunohistochemical analysis of the resected adrenal specimen, in whom hypokalemia and drug-resistant hypertension were resolved after the removal of the affected unilateral adrenal lesion.
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